Human medicines European public assessment report (EPAR): Azacitidine Accord, azacitidine, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Accord, azacitidine, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Metadata
Provider: 
European Medicines AgencyEuropean Medicines Agency
URL: 
https://www.ema.europa.eu/en/medicines/human/EPAR/azacitidine-accordhttps://www.ema.europa.eu/en/medicines/human/EPAR/azacitidine-accord
Retrieved on: 
Saturday, January 6, 2024
Information
Tags: 
Patient, RNA, Medical Subject Headings, Liver, Marketing, INN, Risk, Classification, Bone marrow, ATC, IPSS, International, WHO, B cell, Myeloid tissue, Azacitidine, Myelodysplastic syndrome, CMML, DNA, Nausea, Blood, Language, MDS, Cancer, Abdomen, Death, Myelocyte, European Medicines Agency, Syndrome, Monocyte, Thigh, Growth, Select, HSCT, Anatomy, AML, Pancreatic serous cystadenoma, Acute leukemia, IIA, Skin, Cytidine, Vomiting, Medical device
Geotags: 
EU
Summary
Key Points: 


Human medicines European public assessment report (EPAR): Azacitidine Accord, azacitidine, Date of authorisation: 13/02/2020, Revision: 7, Status: Authorised

Copyright: 
2024 European Medicines Agency. All Rights Reserved.